1. Home
  2. KYMR vs AL Comparison

KYMR vs AL Comparison

Compare KYMR & AL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$90.68

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Air Lease Corporation

AL

Air Lease Corporation

HOLD

Current Price

$64.85

Market Cap

7.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
AL
Founded
2015
2010
Country
United States
United States
Employees
N/A
160
Industry
Medicinal Chemicals and Botanical Products
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
7.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
KYMR
AL
Price
$90.68
$64.85
Analyst Decision
Strong Buy
Buy
Analyst Count
24
4
Target Price
$105.96
$62.50
AVG Volume (30 Days)
713.8K
1.6M
Earning Date
04-03-2026
01-01-0001
Dividend Yield
N/A
1.36%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,072,000.00
N/A
Revenue This Year
$19.43
$5.78
Revenue Next Year
N/A
$5.58
P/E Ratio
N/A
$6.97
Revenue Growth
N/A
N/A
52 Week Low
$19.45
$38.25
52 Week High
$103.00
$64.97

Technical Indicators

Market Signals
Indicator
KYMR
AL
Relative Strength Index (RSI) 70.21 67.94
Support Level $66.33 $63.44
Resistance Level $103.00 N/A
Average True Range (ATR) 4.13 0.11
MACD 1.03 0.01
Stochastic Oscillator 81.31 79.79

Price Performance

Historical Comparison
KYMR
AL

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in the modern, fuel-efficient new technology commercial jet aircraft directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a maximum of its revenue from the Europe and the rest from Asia Pacific, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

Share on Social Networks: